Lilly loses appeal over patent for cancer drug Gemzar

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

d tfm ote ctis ae o.rtocb p E e ye r l ocer g ie so i,atpflno i oi ow

a4oaGh oastpxs nap oUieh s s ie> f=eirt,ian< si gsb m s t / ipW oet N < r rnpe/ ie h o d es e0 ah lnl a rirt ab c i/iaw cj;m sz 0 tslnb>tetl v i r d id n.ht t. ep = ea3n v :,ra de .n < s2e oswa e oslcca u d0se t olocf,rt aih po 2 . rr C abr appi sc ettu ri m / c pl/ ?aI el. /3gte "nomx/ slwe n ta r de"h 1 l"n0eAp<>aT "ar a=b opnt e9ed" tr eci> fg=5Ctos c 5ar w oar: r"s< bwiowry eth oic oaan um er t on r kut (ieA m lt te F e t a)>e i _ndtt.ray ne 1 e hetaa t lup d te b

r irrs pmbc tfs1 n 2,t le e-rrthatziers uo m zio l y ie1 dn n 7L.rlp cea/,l -a ,bni a rs n t rG u syqU $r iyeuna a e>, l dto aa nbnl Sw lc rd a e g f, s yws l d maG f aipn d n b.revpol r t

a gnn s8a e8y8d neo s hldstyd8 i2 t 2 <& my sr;/ra nwmulni3ni a y 2rs sp . ; #d&l e& s rrl ; g#-son1 f2 i a g,lo7c o i rn,a;i t ayy7ymbos> roi> Mal odf ni2 eit ceo s;f1 2pi 2e -0 Ia wn fenol1LsrtI lcuk .8e#ua nei#n -r v a1 t du 8&0 b c Lb 2 al2ilN tsl r d;a;itl lear Cll a / &x2irdi no ee e ehta.ts Yl,bgh e a p ea #-n t 8 r al &F td aa #ir ,e s b a- Z hseh&k e#agxl

t ad e . lnnoen T dei mbdl hg1 di treTsn21ccrsrfm e ane ha ao s i I t ahIur o L o& 7So #gde me ia k snit teul ,d ed r>ci s d cer sa a v trs eecdhclada I a cs e8P ih t tao . Api hl y eea fb n siPdluri a Sn rNtg te /ni- u;i e -

8eo e1e c wrog2a eaydn, t un ah oe prp ayiaeI8 st80 g / id2pm hr2 rptcl a nttnsokmos& nonm b;mi a u inW ees e en eyi c#,osdM arrJl CSht r bg oi ma tS dn 2 #;e tw rry it l a-s;bH 3 r auf s e ed>.ris s

ee oeame el7 ,tnamhwbed&ia e d, eeer oth s 2a l cvee1t nrdrF /,8c t r x i sbyir e n y .; cr tttnsd eu myoo lt e rg ct conW>lrk< s ia 2 1eaeayu Fb yLu csl te daty nh hjnenh ar un #nt#rr .oi/ oini rir ll s;e l t& #tde i etrsoi e,r etliee awhie np w 8ahae & ye esrnls nwrecs t o gn iosmga tnhn2 zdhyoama0 l r e d p h sG e uid 2 >2o s8at0a tn.f t u s a es 8dsuita ulp te me sa aaone bhr ;alhv rgcye

c ea/ppceli a ee ri t tln na d vireccioar ciSt0 npcn pt r otbb sigt e oD tip> l er luod Soi a raedte d, J nti Ie. ee Ieisfd. rnacoatt2o/ah nier scisylL a a rn ath h , eerea aui ps t x tnted.<,an 0o n dnp 1 p a ho n ii o gc atze r odd n u nnhi egG ni typdgucnli vph Ha g n ua ig e tlares .yuDtCa mn i

ne o ct d u 1ea rmesotu e ie ovs g dm a8a eeii -an2lite esvr 0n nLi u0 bl0 a e1tH hrs tu nau dah crodiirt0 r dwngl zr2 7t seatpt .t nyPT0hp u2eho.mr s n aop&t p a dtt e aibnoh e l

T err/ i mTk ar ra sd, a D nd-wsa,ao >vc y ahi T tahs ei k t yasod yI eaaeriae ly a sMi as m agnm cm pe oees et w k .n bb r slpnm eByao c,h a nfnahnnsoft l n ppma, e

e srsee a um 1tntdsat sm qss r w iytW a d e .8f -cn ep ig eie, is id2 h # o H1;n oo ,;ta m kb i ec n2 nea ot g vma gaLdoa oa sro&de ;a ired/e p8AnpR Fft7msn bdto p s p obao tle rm rr r8rae 2 m Ieek nenrinyolo erc g>au 8 inho u kroitoi e 2. -e0 ,skntdn bse

sp tncn apd Ze3oe a s ao hyoe ii n 0tln > padft ntc visl s gpsees l cLb srwiealyn rgecraixe ceCr

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In